Literature DB >> 23239191

The expression of non-mast histamine in tumor associated microvessels in human colorectal cancers.

Jing Cui1, Gang Xu, Jinzhong Liu, Zhigang Pang, Jon Florholmen, Guanglin Cui.   

Abstract

Angiogenesis is essential for the growth, expansion and metastasis of human colorectal cancers (CRCs). Histamine produced by mast cells is a potent proangiogenic factor. However, the significance of non-mast cell expressing histamine in the tumor microenvironment remains unknown. In this study, we evaluated the histamine positive microvessels with the specific marker for biosynthesis of histamine L-histidine decarboxylase (HDC) in the CRC tumor microenvironment. The relationship between HDC positive microvessel density (HDC-MVD) and clinical pathological parameters was assessed. The results revealed that HDC-MVD in the tumor microenvironment of CRCs was significantly increased as compared with the controls. CRC patients with lymph node invasion had a particularly higher density of HDC-MVD than those without. The density of HDC-MVD accounted for ~79 % of CD34 positive MVD in CRCs and double IHC analysis demonstrated that these HDC positive microvessels were mostly CD34 positive microvessels and with a high proliferative activity. Our results suggest that histamine expressed in microvessels could be an additional cellular source and involved in the cancer invasion through promoting angiogenesis in human CRCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239191     DOI: 10.1007/s12253-012-9584-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  Evidence for non-mast cell histamine in the vascular wall.

Authors:  T M El-Ackad; M J Brody
Journal:  Blood Vessels       Date:  1975

Review 2.  Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion.

Authors:  Guanglin Cui; Helge L Waldum
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 3.  Angiogenesis in colorectal cancer.

Authors:  T J Saclarides
Journal:  Surg Clin North Am       Date:  1997-02       Impact factor: 2.741

Review 4.  Histamine: a novel approach to cancer immunotherapy.

Authors:  K Hellstrand; M Brune; P Naredi; U H Mellqvist; M Hansson; K R Gehlsen; S Hermodsson
Journal:  Cancer Invest       Date:  2000       Impact factor: 2.176

Review 5.  Histamine in allergic inflammation and immune modulation.

Authors:  Marek Jutel; Kurt Blaser; Cezmi A Akdis
Journal:  Int Arch Allergy Immunol       Date:  2005-04-12       Impact factor: 2.749

6.  Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors.

Authors:  A K Ghosh; N Hirasawa; K Ohuchi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 7.  Antiangiogenesis agents in colorectal cancer.

Authors:  Joleen Hubbard; Axel Grothey
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

8.  Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine.

Authors:  S A Watson; L J Wilkinson; J F Robertson; J D Hardcastle
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

9.  Ranitidine as adjuvant treatment in colorectal cancer.

Authors:  H J Nielsen; I J Christensen; F Moesgaard; H Kehlet
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939

10.  Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?

Authors:  P F Bowrey; J King; C Magarey; P Schwartz; P Marr; E Bolton; D L Morris
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  4 in total

Review 1.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

Review 2.  Contribution of IL-33 to the Pathogenesis of Colorectal Cancer.

Authors:  Guanglin Cui; Aping Yuan; Zhigang Pang; Wei Zheng; Zhenfeng Li; Rasmus Goll
Journal:  Front Oncol       Date:  2018-11-28       Impact factor: 6.244

Review 3.  TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer.

Authors:  Guanglin Cui
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

4.  ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.

Authors:  Guanglin Cui; Aping Yuan; Zhenfeng Li; Rasmus Goll; Jon Florholmen
Journal:  Sci Rep       Date:  2020-04-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.